Jinfeng Gan

423 total citations
21 papers, 324 citations indexed

About

Jinfeng Gan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jinfeng Gan has authored 21 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Jinfeng Gan's work include Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA modifications and cancer (3 papers). Jinfeng Gan is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA modifications and cancer (3 papers). Jinfeng Gan collaborates with scholars based in China, United States and Hong Kong. Jinfeng Gan's co-authors include Hao Zhang, Lu Wang, Hongmei Dong, Wan‐Wan Lin, Zheng Lin, Dianzheng Zhang, Sai‐Ching J. Yeung, Zhifeng Ning, Jin‐Ping Li and Jiali Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Scientific Reports.

In The Last Decade

Jinfeng Gan

18 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinfeng Gan China	10	203	98	91	51	47	21	324
Runyi Ye China	12	192 0.9×	66 0.7×	142 1.6×	29 0.6×	45 1.0×	15	306
Guinv Hu China	12	237 1.2×	104 1.1×	151 1.7×	38 0.7×	48 1.0×	24	383
Qishun Geng China	11	232 1.1×	86 0.9×	108 1.2×	58 1.1×	55 1.2×	28	382
Sylwia Grodecka-Gazdecka Poland	11	182 0.9×	144 1.5×	105 1.2×	53 1.0×	26 0.6×	35	376
Dimitris C. Kanellis Denmark	10	209 1.0×	85 0.9×	88 1.0×	62 1.2×	31 0.7×	14	323
Maria Concetta Romano Italy	9	154 0.8×	72 0.7×	64 0.7×	23 0.5×	41 0.9×	13	370
Chengjuan Jin China	13	216 1.1×	79 0.8×	116 1.3×	89 1.7×	55 1.2×	21	420
Xiaoli Xie China	9	188 0.9×	81 0.8×	58 0.6×	106 2.1×	26 0.6×	19	329
Rongjie Zhao China	9	162 0.8×	60 0.6×	102 1.1×	22 0.4×	56 1.2×	21	279

Countries citing papers authored by Jinfeng Gan

Since Specialization

Citations

This map shows the geographic impact of Jinfeng Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfeng Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfeng Gan more than expected).

Fields of papers citing papers by Jinfeng Gan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfeng Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfeng Gan. The network helps show where Jinfeng Gan may publish in the future.

Co-authorship network of co-authors of Jinfeng Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfeng Gan. A scholar is included among the top collaborators of Jinfeng Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfeng Gan. Jinfeng Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Jiawei, Xiaotong Guo, Yujing Chen, et al.. (2025). Regulation of disease signaling by YOD1: potential implications for therapeutic strategies. Cancer Cell International. 25(1). 232–232.

Li, Wenqiao, Xiaohao Xu, Jinfeng Gan, et al.. (2025). Multi-Sensor Object Anomaly Detection: Unifying Appearance, Geometry, and Internal Properties. 9984–9993.

Wang, Jiawei, Lihua Zhou, Li Cai, et al.. (2025). USP7-DDX5-FASN axis drives fatty acid metabolism and supports hepatocellular carcinoma progression. Cellular Signalling. 134. 111947–111947.

Zhao, Jiawei, Xiaohui Bai, Jingjing Du, et al.. (2025). Tryptophan metabolism: From physiological functions to key roles and therapeutic targets in cancer (Review). Oncology Reports. 54(1). 1–16. 1 indexed citations

Li, Jin‐Ping, et al.. (2024). The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer. Discover Oncology. 15(1). 123–123. 1 indexed citations

Li, Jin‐Ping, et al.. (2024). GCF2 mediates nicotine-induced cancer stemness and progression in hepatocellular carcinoma. Ecotoxicology and Environmental Safety. 271. 115952–115952. 2 indexed citations

Gan, Jinfeng, et al.. (2024). Innovative phytoceutical-based drug delivery in the management of pulmonary fibrosis: A roadmap towards inhaled therapeutics. Journal of Drug Delivery Science and Technology. 99. 105942–105942. 5 indexed citations

Li, Jin‐Ping, et al.. (2023). Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 149(17). 15763–15779. 14 indexed citations

Qi, Guangying, Jinfeng Gan, Chichu Xie, et al.. (2023). ER‐α36 is involved in calycosin inhibition of IL‐6 production in macrophages. Journal of Cellular and Molecular Medicine. 28(1). 7 indexed citations

10.

Zhou, Zihui, Yu Liu, Tian Liu, et al.. (2022). Depletion of PARP10 inhibits the growth and metastatic potential of oral squamous cell carcinoma. Frontiers in Genetics. 13. 1035638–1035638. 8 indexed citations

11.

Liu, Yu, et al.. (2022). Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis. Scientific Reports. 12(1). 13951–13951. 11 indexed citations

12.

Gong, Yu, et al.. (2022). A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Journal of Oncology. 2022. 1–16. 3 indexed citations

13.

Gan, Jinfeng & Hao Zhang. (2020). PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma. Translational Cancer Research. 9(8). 4800–4810. 8 indexed citations

14.

Wang, Lu, Jinfeng Gan, Zhimeng Yao, et al.. (2019). MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis. iScience. 22. 353–368. 19 indexed citations

15.

Dong, Hongmei, Li Ma, Jinfeng Gan, et al.. (2016). PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2. Oncogene. 36(3). 410–422. 37 indexed citations

16.

Dong, Hongmei, Jinjin Xu, Weiwei Li, et al.. (2016). Reciprocal androgen receptor/interleukin‐6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. The Journal of Pathology. 241(4). 448–462. 42 indexed citations

17.

Gan, Jinfeng, Hongzheng Ren, Hongmei Dong, et al.. (2015). Dysregulation of PAK1 Is Associated with DNA Damage and Is of Prognostic Importance in Primary Esophageal Small Cell Carcinoma. International Journal of Molecular Sciences. 16(6). 12035–12050. 18 indexed citations

18.

Ning, Zhifeng, Jinfeng Gan, Chaoying Chen, Dianzheng Zhang, & Hao Zhang. (2014). Molecular functions and significance of the MTA family in hormone-independent cancer. Cancer and Metastasis Reviews. 33(4). 901–919. 17 indexed citations

19.

Lin, Zheng, Lu Wang, Jinfeng Gan, & Hao Zhang. (2014). RNA activation: Promise as a new weapon against cancer. Cancer Letters. 355(1). 18–24. 42 indexed citations

20.

Zhang, Yuling, Hongzheng Ren, Lu Wang, et al.. (2014). Clinical Impact of Tumor-Infiltrating Inflammatory Cells in Primary Small Cell Esophageal Carcinoma. International Journal of Molecular Sciences. 15(6). 9718–9734. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact